Three current analyst targets stood out in my review. Morgan Stanley raised its rating to Overweight from Equal Weight and lifted the price target to $110 (from $97) in early November 2026, pointing to systematic demand after the third-quarter results. Evercore ISI kept a Hold rating with a $102 target, while RBC Capital held a Hold stance with an $88 target (up from $85). I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The arithmetic mean of all three targets comes to $100, roughly 4% above the latest price. Applying the minimum-distance rule, the central target instead averages only those above the current price—Morgan Stanley’s $110 and Evercore ISI’s $102—which rounds to $106. The full range of $88 to $110 underscores real disagreement on whether Acadian’s momentum supports a premium multiple.
Shares recently traded near $96.05, so a move to $106 implies upside of about 10%. The stock has already more than doubled over the past 12 months, meaning further progress hinges on whether earnings growth can sustain the rerating. Trailing EPS has risen sharply, and the forward P/E near the mid-teens remains well below the trailing multiple around 27x, indicating the market already prices in solid growth.
The company posted record AUM and Q3 2026 ENI EPS of $1.36 versus consensus near $1.21, plus $2.6 billion in quarterly net inflows—about 4% annualized organic growth. Management targets a 38%–40% fiscal 2026 margin. Continued delivery here would be the clearest path forward. From what I see, these metrics remain worth monitoring closely.
The 52-week high of $98.52 stands as the next key resistance, followed by the psychological $100 level. Clearing both would clear the way toward $106. Support appears to be forming in the $86 to $91 zone, near where the stock consolidated after the Q3 report. A break below that range would weaken the constructive setup and raise questions about the path ahead. I’m watching this closely for any shift in momentum.
Analyst targets generally reflect a roughly 12-month horizon. Investors should track quarterly earnings and guidance, AUM and net-flow updates, further analyst changes, and broader equity-market conditions that affect both investment performance and fee revenue. For an asset manager, market volatility and relative performance matter as much as company-specific execution.
The $106 central target represents the average of the two verified analyst targets above the current price and would require a gain of roughly 10% from recent levels near $96.05. The bull case rests on record AUM, robust inflows, margin expansion, and improving analyst views, while the bear case highlights a richer valuation, concentration in systematic strategies, and a target range that still includes downside. With the full analyst range spanning $88 to $110, disagreement remains wide. Reaching $106 will likely depend on sustained organic growth, continued earnings beats, and a decisive break above the 52-week high.
In my own research process, Tickeron’s AI Daily Buy/Sell Signals provide a helpful layer of insight. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on shifting market conditions and technical behavior. For a name moving as quickly as Acadian, these signals serve as a practical complement to fundamental analysis and analyst commentary, helping me stay on top of potential trend changes without replacing deeper due diligence.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
AAMI moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 37 of 49 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 36 of 55 cases where AAMI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 65%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on AAMI as a result. In 61 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for AAMI just turned positive on November 09, 2026. Looking at past instances where AAMI's MACD turned positive, the stock continued to rise in 33 of 51 cases over the following month. The odds of a continued upward trend are 65%.
Following a +4.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where AAMI advanced for three days, in 232 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
AAMI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day moving average for AAMI crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AAMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
The Aroon Indicator for AAMI entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 10 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. AAMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: AAMI's P/B Ratio (35.089) is very high in comparison to the industry average of (2.412). P/E Ratio (32.028) is within average values for comparable stocks, (-2.386). Projected Growth (PEG Ratio) (0.110) is also within normal values, averaging (1.319). Dividend Yield (0.004) settles around the average of (0.270) among similar stocks. P/S Ratio (4.771) is also within normal values, averaging (15.694).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of investment advice and asset management services
Industry InvestmentManagers